ArticleFrontiers in psychiatry2026
Multiplex functional connectome graph transformer for cognitive vulnerability in dialysis-treated chronic kidney disease.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Chronic kidney disease (CKD) requiring maintenance dialysis is accompanied by cognitive vulnerability and distributed brain-network dysfunction. This study evaluated whether complementary resting-state functional magnetic resonance imaging (rs-fMRI) connectome views could support subject-level characterization of CKD-related neurocognitive brain dysfunction. Methods: We analyzed a de-identified rs-fMRI dataset of 100 participants, including 52 patients with CKD receiving maintenance dialysis and 48 normal controls (NCs). The CKD group had lower Mini-Mental State Examination and Montreal Cognitive Assessment scores. AAL116 regional time series were represented as three 116 × 116 graph views: Pearson correlation, sparse representation, and Granger causality mapping. We developed MTGAF, a multiplex graph transformer combining modality-specific graph encoding, graph-transformer refinement, disease-aware readout, cross-modal attention, and adaptive fusion. Performance was evaluated with participant-level stratified 5-fold cross-validation and compared with BrainNetTF, BrainGNN, SVM, Random Forest, single-modality variants, and additional component-ablation variants. Robustness was assessed using pooled confusion matrices, bootstrap confidence intervals, calibration summaries, paired comparisons, and ROI importance analysis. Results: MTGAF achieved accuracy 0.8800 ± 0.0678, macro-F1 0.8796 ± 0.0680, and AUC 0.9297 ± 0.0437. The pooled confusion matrix contained 42 true negatives, 46 true positives, 6 false positives, and 6 false negatives. Bootstrap 95% CIs were 0.8100-0.9400 for accuracy, 0.8095-0.9396 for macro-F1, and 0.8696-0.9770 for pooled AUC. The full PC-SR-GCM model achieved higher accuracy and macro-F1 than single-modality variants. ROI importance highlighted cingulate, temporoparietal, sensorimotor, visual-association, frontostriatal, posterior cingulate, and temporal-association systems. Conclusions: Multiplex modeling of complementary connectome information provides signals for characterizing CKD-related neurocognitive brain-network dysfunction. MTGAF is a research-stage imaging-AI framework for individualized brain-risk characterization in dialysis-treated CKD and should be further evaluated in larger multi-center cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.